PKNOX2 and neoplasm: In summary, our study indicated for the first time that PKNOX2 functions as a candidate tumor suppressor in GC by induction of apoptosis, inhibition of cell cycle progression and blockade of EMT, culminating in inhibition of cell growth, migration/invasion in vitro and tumorigenicity in vivo.